Phase II Treatment of Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme Treated With Gliadel Wafers [carmustine polifeprosan-20 wafer], Surgery and Limited Field Radiation Plus Concomitant Temozolomide Followed by Temozolomide.
Phase of Trial: Phase II
Latest Information Update: 02 Nov 2016
At a glance
- Drugs Carmustine polifeprosan 20 wafer; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions
- 24 Mar 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Jan 2008 New trial record.